HOMOCYSTEINE AND PROGRESSION OF ATHEROSCLEROSIS

同型半胱氨酸与动脉粥样硬化的进展

• 批准号: 6116921
• 负责人: JOHN M PORTER
• 金额: $ 3.13万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6116921
• 关键词: atherosclerosis; blood chemistry; cardiovascular disorder chemotherapy; cerebrovascular disorders; clinical research; folate; homocysteine; human subject; human therapy evaluation; longitudinal human study; pathologic process; peripheral blood vessel

This is a prospective clinical study designed to evaluate the rate of progression of atherosclerotic lower extremity (LED) and cerebrovascular (CVD) disease in a population of patients with LED and/or CVD. The study will examine the relationships between progression of atherosclerosis, level of plasma homocysteine (HC), and treatment to lower plasma HC (folic acid) in patients. The study will occupy eight years.

这是一项前瞻性临床研究，旨在评估